Proposed pharma tariffs may spike US drug prices by 12.9%: EY report
The pharmaceutical industry is warning that such tariffs could disrupt supply chains, raise production costs, hurt export competitiveness, and endanger up to 490,000 export-related jobs. …
The pharmaceutical industry is warning that such tariffs could disrupt supply chains, raise production costs, hurt export competitiveness, and endanger up to 490,000 export-related jobs. …
Read More
About Author
